Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UnbornHeart was a Finland-based maternal health and digital health company centered on a home fetal heart monitoring product branded UnbornHeart. The offering combined a fetal Doppler device with a mobile application that let pregnant users listen to, record, visualize, and share fetal heartbeat measurements. Available public information indicates the product was marketed as a CE-certified and FDA-cleared home baby heartbeat monitor and was associated with Odosoft Ltd in Oulu, Finland. The business appears to have been a consumer-focused pregnancy monitoring and mobile health venture rather than a therapeutics developer. Public company-directory sources now indicate the operating company is closed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UnbornHeart.